Cas 110997-49-4,N-Methyl-N-[ 4-(2-(3,4-dimethoxyphenyl)ethyl)phenyl]-2-hydroxy-α-oxo-benzeneacetamide

110997-49-4

Post Buying Request

Basic information

Product Name: N-Methyl-N-[ 4-(2-(3,4-dimethoxyphenyl)ethyl)phenyl]-2-hydroxy-α-oxo-benzeneacetamide
Synonyms:
CAS NO:110997-49-4
Molecular Formula:
Molecular Weight: 419.477
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N-Methyl-N-[ 4-(2-(3,4-dimethoxyphenyl)ethyl)phenyl]-2-hydroxy-α-oxo-benzeneacetamide(CAS DataBase Reference)
NIST Chemistry Reference: N-Methyl-N-[ 4-(2-(3,4-dimethoxyphenyl)ethyl)phenyl]-2-hydroxy-α-oxo-benzeneacetamide(110997-49-4)
EPA Substance Registry System: N-Methyl-N-[ 4-(2-(3,4-dimethoxyphenyl)ethyl)phenyl]-2-hydroxy-α-oxo-benzeneacetamide(110997-49-4)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 110997-49-4(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

110997-49-4 Suppliers

Recommended suppliers

110997-49-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 110997-49-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,0,9,9 and 7 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 110997-49:
(8*1)+(7*1)+(6*0)+(5*9)+(4*9)+(3*7)+(2*4)+(1*9)=134
134 % 10 = 4
So 110997-49-4 is a valid CAS Registry Number.

110997-49-4Upstream product

40785-55-5 (2-hydroxyphenyl)-glyoxylic acid ethyl ester

110997-49-4Downstream Products

110997-49-4Relevant academic research and scientific papers

N-SUBSTITUTED-2-HYDROXY-ALPHA-OXO-BENZENEACETAMIDES AND PHARMACEUTICAL COMPOSITIONS HAVING ACTIVITY AS MODULATORS OF THE ARACHIDONIC ACID CASCADE

-

, (2008/06/13)

The present invention relates to novel N-substituted 2-hydroxybenzamide and N-substituted 2-hydroxy-alpha-oxo-benezene acetamide compounds pharmaceutical compositions, and methods of use for therefore for the treatment of diseases in which products having lipoxygenase enzyme activity contribute to the pathological condition. Selected novel intermediates are also the present invention

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 110997-49-4